Additionally, in vivo experiments further confirmed that RICTOR knockdown effectively negated the impact of KLF4 silencing, as evident from weekly tumor volume measurements and final tumor weight determinations (Figure 4I). The gene discussed is RICTOR; the disease is neoplasm.